Mergers and growth Pattern Health merged with Greenlight Health Data Solutions in December 2024, indicating expansion and potential cross-sell opportunities to an extended client base including academic researchers, CROs, and biopharma organizations.

No-code platform The no-code configuration tools and comprehensive catalog of clinical outcomes assessments position Pattern Health as a conduit for researchers and clinicians to rapidly deploy digital health programs, suggesting upsell of customization, training, and managed services.

ILD and orthopaedics Recent development of the EMPOWER app for ILD and the orthopaedic risk assessment tool highlight capabilities in specialized disease areas, offering focused sales angles to units pursuing respiratory and musculoskeletal trial programs.

Home-based programs Past initiatives like home-based cardiac rehab and digital health programs signal demand for scalable remote patient engagement, enabling cross-sell to health systems and researchers seeking remote trial and intervention platforms.

Financing and reach With a $9M funding backdrop and revenue in the low-to-mid seven figures, Pattern Health can be positioned for growth partnerships, channel partnerships, and enterprise deals with larger health systems and pharmaceutical sponsors seeking digital trial infrastructure.